Related Experiment Video
Updated: Jan 18, 2026

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
[Research progress of upadacitinib in the treatment pediatric rheumatic and autoimmune diseases]
B C Liang1, X W Luo1, Y H Zhao1
1Department of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing 400014, China.
No abstract available in PubMed .
Related Concept Videos
The JAK-STAT Signaling Pathway
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Rheumatic Heart Disease III: Medical Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

